0001127602-11-027658.txt : 20111025
0001127602-11-027658.hdr.sgml : 20111025
20111025161327
ACCESSION NUMBER: 0001127602-11-027658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111021
FILED AS OF DATE: 20111025
DATE AS OF CHANGE: 20111025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAGEMANN ROBERT
CENTRAL INDEX KEY: 0001222676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 111156869
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2011-10-21
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222676
HAGEMANN ROBERT
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
1
SVP & Chief Financial Officer
Common Stock
2011-10-21
4
M
0
1650
35.5325
A
141313
D
Common Stock
2011-10-21
4
M
0
2500
48.74
A
143813
D
Common Stock
2011-10-21
4
S
0
4150
49.29
D
139663
D
Common Stock
1766
I
SDCP
Stock Options (Right to Buy)
35.5325
2011-10-21
4
M
0
1650
0
D
2012-02-27
Common Stock
1650
6600
D
Stock Options (Right to Buy)
48.74
2011-10-21
4
M
0
2500
0
D
2012-02-22
Common Stock
2500
10000
D
The options vested in three installments on April 17, 2003, February 27, 2004 and February 27, 2005.
The options vested in three annual installments on February 22, 2006, February 22, 2007 and February 22, 2008.
This exercise and sale reported were effected pursuant to Rule 10b-5-1 sales plan adopted by the reporting person on February 7, 2011.
The amount includes exempt purchases made under the Company's stock purchase plan.
These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann
2011-10-25